# US 2013/0280234 A1 · Treatment and Composition for Wound Healing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0280234 A1
- Document ID: US20130280234A1
- Status: Published application
- Kind: A1
- Application number: 12/504,898
- Filed: 2009-07-17
- Published: 2013-10-24
- Earliest claimed: 2001-06-13
- Assignees: The University of Sydney
- Inventors: Christopher John Jackson; Philip Neil Sambrook
- Web page: https://patentgrep.com/patent/US20130280234A1

## CPC

- A61K 38/4866: {Protein C (3.4.21.69)}
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 19/04: for non-specific disorders of the connective tissue
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A method and medicament for promoting wound healing in a subject is disclosed. The medicament comprises an effective amount of an agent comprising one or more of; (i) an activated protein C (APC), (ii) a functional fragment of an APC, (iii) an APC mimetic compound, and (iv) protein C. Delivery systems including gels, sponges, gauzes and meshes incorporating the agent for topical administration are also described.

## Claims

### Claim 1

A method for promoting wound healing in a subject, said method comprising topically administering to said subject an effective amount of an agent comprising an activated protein C (APC), optionally in admixture with a pharmaceutically-acceptable carrier.

### Claim 2 (depends on 1)

The method of claim 1, wherein the agent is human APC.

### Claim 3 (depends on 1)

The method of claim 1, wherein the agent is administered to said subject within 1 to 10 hours of wounding.

### Claim 4 (depends on 1)

The method of claim 1, wherein the wound for which wound healing is to be promoted is selected from the group consisting of dermal ulcers, burns, oral wounds, eye wounds, non-cutaneous wounds, ischemia-reperfusion injury, bone and cartilage damage and warfarin-related skin necrosis.

### Claim 5 (depends on 4)

The method of claim 4, wherein the wound for which wound healing is to be promoted is a dermal ulcer.

### Claim 6 (depends on 1)

The method of claim 1, wherein the effective amount of the agent is in the range of 0.1 to 1000 μg per kg of body weight.

### Claim 7 (depends on 6)

The method of claim 6, wherein the effective amount of the agent is in the range of 0.1 to 10 μg per kg of body weight.

### Claim 8 (depends on 1)

The method of claim 1, wherein the wound for which wound healing is promoted is an epithelial wound.
